AMRYT PHARMA PLC's ticker is AMYT and the CUSIP is 03217L106. A total of 67 filers reported holding AMRYT PHARMA PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,300,829 | +5.5% | 315,182 | 0.0% | 0.59% | -1.0% |
| Q3 2022 | $2,181,000 | -1.0% | 315,182 | 0.0% | 0.60% | +15.6% |
| Q2 2022 | $2,203,000 | -15.4% | 315,182 | 0.0% | 0.52% | -2.6% |
| Q1 2022 | $2,603,000 | -23.5% | 315,182 | 0.0% | 0.53% | -21.8% |
| Q4 2021 | $3,403,000 | -30.9% | 315,182 | -22.6% | 0.68% | -35.0% |
| Q3 2021 | $4,925,000 | – | 407,440 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,857,268 | $61,912,000 | 26.04% |
| Stonepine Capital Management, LLC | 6,298,348 | $44,025,000 | 20.48% |
| MPM ASSET MANAGEMENT LLC | 2,668,843 | $18,655,000 | 7.87% |
| Aquilo Capital Management, LLC | 1,866,652 | $13,048,000 | 4.45% |
| New Leaf Venture Partners, L.L.C. | 449,737 | $3,144,000 | 2.04% |
| Global Frontier Investments LLC | 435,000 | $3,040,000 | 1.42% |
| Rubric Capital Management LP | 3,600,000 | $25,164,000 | 1.32% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,333,552 | $44,272,000 | 1.01% |
| Telemetry Investments, L.L.C. | 121,670 | $850,000 | 1.01% |
| Clearline Capital LP | 631,942 | $4,417,000 | 0.57% |